Mr
Bernhard
Ganahl

Partner & Patent Attorney

Munich Office Salzburg Office

Telephone. +49(0) 891 259 9600
Mobile. +49(0) 160 357 0500
Email. [email protected]

Experience

Bernhard's main focus lies in the drafting and handling of patents in the areas of electric engineering, software inventions as well as devices for biotechnology and optics. Furthermore he possesses great experience in opposition cases and IP litigation cases as well as trade mark protection.

Bernhard studied Applied Physics at the Technical University of Munich. He has been in the IP business since 1990. He was accredited as a German Patent Attorney in 1994 and in the same year also qualified as a European Patent Attorney.

He has made his name as a specialist legal author with, amongst others, with the article “Patent situation in the field of DNA chip technology in Europe” (which appeared in no. 12/2000 of medgen, the newsletter of the German Association for Human Genetics) and the article “Is the core theory once again topical?” (which appeared in the Transactions of German Patent Attorneys in December 2003), dealing with German case law in respect of software inventions. This article was cited by the Enlarged Board of Appeal in the up to now only decision (G 03/08) relating to computer implemented inventions. He regularly gives lectures on different topics in IP law.

Bernhard is a member of the Licensing Executive Society (LES) and the European Patent Experts Exchange (EuPEX).

Specialisms

  • AI
  • Scientific instruments

Industries

  • Medical devices icon Medical devices

Services

  • Copyright & database rights
  • Due diligence
  • Patent oppositions & appeals
  • Patents
  • Searching & competitor monitoring
  • Strategy
  • Transactional IP & commercial support
  • Utility models

Qualifications

Patent Attorney

Austrian
European
German

Trade Mark Attorney

Austrian
European
German


OTHER

Dipl. Phys.

Publications

From March 1 Patronus IP have merged with HGF

View publication online

G1/19: EPO oral proceedings

View publication online

Conferences: 2021

October 29th 2021

APAA 2021

Attending

Event details

Conferences: 2020

July 15th 2020

G1 19 hearing at the EPO

Attended

Event details

Related News

Managing Intellectual Property IP Stars & Firm Rankings 2021

Managing Intellectual Property IP Stars 2021, comprising the highly recommended IP professionals, has now been published. HGF is delighted to have 14 European attorneys listed. IP STARS is the leading …

Read article

Medical technology most patented subject matter at EPO in 2020

Pharmaceutical and biotechnology patent applications also make top 10 most patented. Recent statistics published by the EPO show that a total of 14,295 European patent applications were filed in 2020 …

Read article

The EPO ‘How To’ guide for antibody applications in Europe

The 2021 EPO Guidelines provide much needed guidance on how to protect antibodies in Europe. Biological drugs including therapeutic antibodies have become increasingly important to the pharmaceutical industry. The European …

Read article

Personalised drug patenting in Europe

Opportunities for additional pharmaceutical product patent protection in Europe, based on the use of a drug to treat a patient exhibiting a biomarker indicative of drug response. Recent years have …

Read article

The Internet of Medical Things

Exploring the growth of patents for connected medical devices, and how best to protect them. The Internet of Things (IoT) is expected to change our lives by creating a connected …

Read article

Covid-19 vaccine patent waivers

To waive, or not to waive, that is the question. The earliest identified date of a patient presenting with symptoms of a “novel coronavirus” in Wuhan, China is reported to …

Read article

G1/21 hearing at the EPO

Follow this page for the updates from G1/21 hearing at the EPO on 28th May 2021. HGF Partners Dr Chris Moore and Douglas Drysdale will be reporting all the key …

Read article
Event - 9th June 2021

Webinar: Developing effective patent strategies for personalised medical devices in Europe and the US

HGF in Europe and Knobbe Martens in the US are holding a joint webinar on 9th June. In this webinar we will explore considerations for implementing an effective strategy to …

Event details

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.